Intralytix is a biotechnology company headquartered in Baltimore, Maryland, USA. They specialize in the development and commercialization of bacteriophage-based products for food safety and human health. Bacteriophages are natural enemies of disease-causing bacteria and can effectively kill specific bacteria without harming the rest of the microbiome, providing an unprecedented level of safety for antimicrobials.

Intralytix's products are focused on controlling bacterial pathogens in environmental, food processing, and medical settings. These products include ListShield™, which targets Listeria monocytogenes contamination, EcoShield™ PX, which targets Shiga toxin-producing Escherichia coli (STEC), and SalmoFresh™, which targets highly pathogenic Salmonella serotypes. Intralytix has received grants from reputable institutions like the U.

S. Department of Agriculture for optimizing their bacteriophage preparations at poultry and meat producers. With a strong emphasis on research and innovation, Intralytix is dedicated to revolutionizing food safety and human health through the power of bacteriophages.

Contact them via email at info@intralytix. com or sales@intralytix. com for more information